Systemic mastocytosis

Hematol Oncol Clin North Am. 2011 Oct;25(5):1067-83, vii. doi: 10.1016/j.hoc.2011.09.012.

Abstract

An unusual disease, mastocytosis challenges the pathologist with a variety of morphologic appearances and heterogeneous clinical presentations ranging from skin manifestations (pruritus, urticaria, dermatographism) to systemic signs and symptoms indicative of mast cell mediator release, including flushing, hypotension, headache, and anaphylaxis among others. In this article, we focus on recognizing the cytology, histopathology, clinical features, and prognostic implications of systemic mastocytosis, a clonal and neoplastic mast cell proliferation infiltrating extracutaneous organ(s) with or without skin involvement. Diagnostic pitfalls are reviewed with ancillary studies to help unmask the mast cell and exclude morphologic mimics.

Publication types

  • Review

MeSH terms

  • Amino Acid Substitution
  • Humans
  • Mast Cells / enzymology*
  • Mast Cells / pathology
  • Mastocytosis, Systemic* / classification
  • Mastocytosis, Systemic* / diagnosis
  • Mastocytosis, Systemic* / enzymology
  • Mastocytosis, Systemic* / genetics
  • Mutation, Missense
  • Myeloproliferative Disorders* / classification
  • Myeloproliferative Disorders* / diagnosis
  • Myeloproliferative Disorders* / enzymology
  • Myeloproliferative Disorders* / genetics
  • Myeloproliferative Disorders* / pathology
  • Prognosis
  • Proto-Oncogene Proteins c-kit / genetics
  • Proto-Oncogene Proteins c-kit / metabolism*
  • World Health Organization

Substances

  • Proto-Oncogene Proteins c-kit